The statements regarding Herpafend have not been evaluated by the Food and Drug Administration (FDA). This product is not ...
Background:Respiratory viruses, including influenza viruses, respiratory syncytial virus (RSV), coronaviruses, and other emerging zoonotic pathogens, remain ...
STAT Wunderkind Sydney Ramirez is revealing the immune system in our nasal passages and working toward better disease ...
Preclinical data support Abalos’ first-in-class approach of safely harnessing the immunostimulatory and anti-tumoral properties of arenaviruses to treat solid tumors -- Düsseldorf, Germany, October 14 ...
Investing.com -- CERo Therapeutics (NASDAQ:CERO), a T cell therapy biotech company, is open to licensing deals or a potential sale while awaiting data on its lead asset, according to Axios, citing CEO ...
Seven UCSF investigators are receiving the prestigious award for their research from the National Institutes of Health.
Abstract: Orthogonal time frequency space (OTFS) modulation has recently gained recognition as a promising modulation scheme for high-mobility communication systems ...
A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and ...
The super adjuvant vaccine also protected against the spread of cancer to the lungs. When exposed to melanoma cells systemically, which mimics how cancer metastasizes, none of the ...
A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled "ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL ...
ACTM-838 showed durable anti-tumor efficacy in multiple murine tumor models and synergized with anti-PD1 therapy in ...
BriaCell Therapeutics ( ($TSE:BCT) ) has shared an announcement. BriaCell Therapeutics Corp. announced that it will present preclinical data on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback